[Email id of designated official for the purpose of grievance redressal]
AUDITED FINANCIAL RESULTS FOR THE QUARTER/YEAR ENDED MARCH'2014 |
|||||
---|---|---|---|---|---|
(Rs. In lacs.) | |||||
PARTICULARS | AUDITED Quarter 31.03.14 | UNAUDITED Quarter 31.12.13 | AUDITED Quarter 31.03.13 | AUDITED Year ended 31.03.2014 | AUDITED Year End 31.03.2013 |
(12 months) | (9 months) | ||||
INCOME FROM OPERATIONS | 11742.89 | 10578.29 | 13154.55 | 56979.97 | 39312.23 |
TOTAL INCOME FROM OPERATIONS | 11742.89 | 10578.29 | 13154.55 | 56979.97 | 39312.23 |
EXPENDITURE | |||||
COST OF MATERIALS CONSUMED | 8993.36 | 8223.32 | 10642.52 | 38560.03 | 28762.65 |
CHANGE IN INVENTORIES F.G./W.I.P | -173.05 | -609.94 | -180.22 | 7289.27 | 22.23 |
EMPLOYEES BENEFIT EXPENSES | 1201.69 | 1115.30 | 1233.67 | 4512.57 | 4081.51 |
DEPRECIATION/AMORTISATION | 683.55 | 671.58 | 416.38 | 2626.44 | 1848.21 |
OTHER EXPENDITURE | 2435.74 | 2212.62 | 3346.94 | 10029.91 | 8685.13 |
TOTAL EXPENDITURE | 13141.29 | 11612.88 | 15459.29 | 63018.22 | 43399.73 |
PROFIT FROM OPERATIONS | -1398.40 | -1034.59 | -2304.74 | -6038.25 | -4087.50 |
OTHER INCOME | 625.91 | 231.80 | 57.31 | 1280.11 | 634.38 |
PROFIT BEFORE FINANCE COST | -772.49 | -802.79 | -2247.43 | -4758.14 | -3453.12 |
FINANCE COST | -377.04 | 2896.77 | 2616.42 | 7675.57 | 8641.10 |
PROFIT BEFORE TAX | -395.45 | -3699.56 | -4863.85 | -12433.71 | -12094.22 |
PROVISION FOR TAX | nil | nil | nil | nil | nil |
MAT CREDIT ENTITLEMENT | nil | nil | nil | nil | nil |
PROVISION FOR DEFFERED TAX | (877.38) | 0.00 | (965.43) | (877.38) | (965.43) |
NET PROFIT | 481.93 | -3699.56 | -3898.42 | -11556.33 | -11128.79 |
PAID UP EQUITY SHARE CAPITAL Rs. 2/- | 1006.94 | 923.57 | 923.57 | 1006.94 | 923.57 |
RESERVE EXCLUDING REVALUATION RESERVES | 18657.40 | ||||
EARNING PER SHARE RS. 2/- EACH | |||||
BASIC | 1.02 | -8.01 | -8.44 | -24.49 | -24.10 |
DILUTED | 1.00 | -8.01 | -8.44 | -23.94 | -24.10 |
A) PARTICULARS OF SHAREHOLDING | |||||
Public Shareholding | |||||
Number of Shares | 24074249 | 24074249 | 24074249 | 24074249 | 24074249 |
% of Shareholding | 47.82 | 52.13 | 52.13 | 47.82 | 52.13 |
Promoters and Promoter Group Shareholding | |||||
a) Plegded/Encumbered | |||||
Number of shares | 22104121 | 22104121 | 22104121 | 22104121 | 22104121 |
Percentage of shares (as a % of total shareholding | |||||
Promoter & Promoter Group) | 84.13 | 100 | 100 | 84.13 | 100 |
Percentage of shares (as a % of total shareholding | |||||
Company) | 43.90 | 47.87 | 47.87 | 43.90 | 47.87 |
b) Non - encumbered | |||||
Number of shares | 4168571 | Nil | nil | 4168571 | nil |
Percentage of shares (as a % of total shareholding | |||||
Promoter & Promoter Group) | 15.87 | Nil | nil | 15.87 | nil |
Percentage of shares (as a % of total share Capital of | |||||
Company) | 8.28 | Nil | nil | 8.28 | nil |
Particulars | Quarter Ended | ||||
31-03-2014 | |||||
INVESTOR COMPLIANTS | |||||
Pending at the beginning of the Quarter | Nil | ||||
Received during the Quarter | 2 | ||||
Disposed off during the quarter | 2 | ||||
Remaining unsolved at the end of the quarter | Nil | ||||
Notes : - | |||||
1. During the quarter under review, the net profits of the company are Rs. 481.93 lacs as compared to net loss of Rs. 3898.42 lacs during same period previous year. | |||||
2.The previous year figures are not comparable as financial year ended 31st March 2013 consisted of nine moths period only. | |||||
3. The company is exclusively in Pharmaceutical segment. | |||||
4. Previous year figures have been re-grouped/ re-arranged wherever necessary | |||||
5. The above results were taken into record by the Audir Committee and the Board of Directors of the company in their respective meetings held on June 04, 2014. | |||||
For Behalf of Board of Directors | |||||
Date: June 04,2014 | (Dr. Gopal Munjal) | ||||
Place: Chandigarh | Managing Director & CEO |